1.
Fadhil HR, Al-Jumaili AA, Al Ani N. Comparison between Reference Infliximab (Remicade) and its Biosimilar (Remsima) in Patients with Ankylosing Spondylitis: A Field-based Pharmacoeconomic Study . Al-Kindy Col. Med. J [Internet]. 2023 Apr. 30 [cited 2024 May 18];19(1):100-5. Available from: https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/908